CoMira™ Logix Smart® COVID-19 test kit
Boost speed and accuracy with real-time PCR testing
How It Works
Ready-to-use Master Mix
Includes the complete mix for convenience and an Internal Positive Control - Human RNaseP gene marker
Positive Control
Synthetic control intended to amplify all targets included in the kit to ensure integrity
Negative Control
Acts as a negative control to verify Master Mix is free from contamination
Clinical Applications
Patient Diagnosis
Accurate detection of SARS-CoV-2 infection for symptomatic and asymptomatic patients.
Screening Programs
Support population screening and surveillance efforts in healthcare and community settings.
Clinical Laboratories
Designed for use by clinical laboratories with qualified personnel following FDA authorization.
Clinical Benefits
FDA-Authorized Accuracy
Meets FDA standards for diagnostic testing performance
Enhanced Reliability
Dual-target detection reduces false negatives
Timely Results
Rapid turnaround supports effective patient management
Quality Controls
Built-in controls ensure result validity
Performance Specifications
| Intended Use | Qualitative real-time RT-PCR test for SARS-CoV-2 RdRp detection |
| Sample Types | Lower/upper respiratory tract fluids and swabs |
| Limit of Detection | 4.29 copies/μl |
| Analytical Sensitivity | 100% (96-100%) |
| Analytical Specificity | 100% (96-100%) |
| Time to Detection | 63-90 minutes |
| Extraction System | QIAamp® RNA Viral Mini Kit |
| Compatible Equipment | CoMira Box™ |
Order Information
Contact us for ordering information and to learn more about implementing the CoMira Logix Smart COVID-19 FDA EUA test in your laboratory.
Contact Us